` MKGAF (Merck KGaA) vs BAS (Basf Se) Comparison - Alpha Spread

MKGAF
vs
BAS

Over the past 12 months, MKGAF has underperformed BAS, delivering a return of +6% compared to the BAS's +22% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
MKGAF
BAS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

MKGAF Intrinsic Value
LOCKED
Unlock
BAS Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Merck KGaA
OTC:MKGAF
137.92 USD
Basf Se
XETRA:BAS
52.77 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
MKGAF, BAS

MKGAF
BAS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Merck KGaA
Revenue
Basf Se
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
MKGAF, BAS

MKGAF
BAS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Merck KGaA
OTC:MKGAF
Basf Se
XETRA:BAS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

MKGAF
59.3%
BAS
23.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Merck KGaA
Basf Se

Operating Margin

MKGAF
20.2%
BAS
4.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Merck KGaA
Basf Se

Net Margin

MKGAF
12.4%
BAS
2.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Merck KGaA
Basf Se

FCF Margin

MKGAF
9.4%
BAS
2.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Merck KGaA
Basf Se

ROE

MKGAF
8.9%
BAS
4.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Merck KGaA
Basf Se

ROA

MKGAF
5.1%
BAS
2.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Merck KGaA
Basf Se

ROIC

MKGAF
7.5%
BAS
2.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Merck KGaA
Basf Se

ROCE

MKGAF
10.3%
BAS
4.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Merck KGaA
Basf Se

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
MKGAF, BAS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MKGAF, BAS

Performance Gap Between MKGAF and BAS
LOCKED
Unlock

Performance By Year
MKGAF, BAS

Loading
MKGAF
BAS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare MKGAF to other stocks
TMO
Thermo Fisher Scientific Inc
More expensive
vs MKGAF
DHR
Danaher Corp
More expensive
vs MKGAF
LLY
Eli Lilly and Co
More expensive
vs MKGAF
JNJ
Johnson & Johnson
More expensive
vs MKGAF
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett